The IgG1 isotype of anti-MDA5 antibody may dominate severity of interstitial lung disease in dermatomyositis

被引：0
|
作者：
Chen, M. [1 ]
Zheng, J. [1 ]
Pan, M. [1 ]
Cao, H. [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Affiliated Ruijin Hosp, Dept Dermatol, Shanghai, Peoples R China
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2020年 / 140卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
903
引用
收藏
页码：S119 / S119
页数：1
相关论文
共 50 条
  • [21] Efficacy of tofacitinib for slowly progressive interstitial lung disease in a patient with anti-MDA5 antibody-positive dermatomyositis
    Takatani, Ayuko
    Koga, Tomohiro
    Fujita, Yuya
    Fukui, Shoichi
    Endo, Yushiro
    Shimizu, Toshimasa
    Kawakami, Atsushi
    CLINICAL IMMUNOLOGY, 2020, 215
  • [22] Anti-MDA5 antibody-positive dermatomyositis with rapidly progressive interstitial lung disease: report of two cases
    Mehta, Asmita A.
    Paul, Tisa
    Cb, Mithun
    Haridas, Nithya
    BMJ CASE REPORTS, 2021, 14 (04)
  • [23] Multidisciplinary approach to anti-MDA5 antibody-positive dermatomyositis associated with rapidly progressive interstitial lung disease
    Witkowska, Anna Barbara
    Cowley, Sharon
    Dempsey, Philip
    Stack, John
    BMJ CASE REPORTS, 2022, 15 (03)
  • [24] Serum uric acid, a potential biomarker for interstitial lung disease in anti-MDA5 antibody-positive dermatomyositis
    Xie, Huaiya
    Fan, Junping
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 69
  • [25] Anti-MDA5 dermatomyositis and progressive interstitial pneumonia
    Silveira, M. G.
    Selva-O'Callaghan, A.
    Ramos-Terrades, N.
    Arredondo-Agudelo, K. V.
    Labrador-Horrillo, M.
    Bravo-Masgoret, C.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2016, 109 (01) : 49 - 50
  • [26] Efficacy and safety of combined immunosuppressive therapies in anti-MDA5 dermatomyositis with interstitial lung disease
    Nguyen, Chilan
    Ennis, Samantha
    Nguyen, John Trinh
    Ta, Brenda
    Tho Phu Pham
    Parsons, Stephen
    RESPIROLOGY, 2023, 28 : 411 - 412
  • [27] Anti-MDA5 Associated Clinically Amyopathic Dermatomyositis With Rapidly Progressive Interstitial Lung Disease
    Tavakolian, Kameron
    Odak, Mihir
    Mararenko, Anton
    Ilagan, Justin
    Douedi, Steven
    Khan, Taimoor
    Al Saoudi, Ghadier
    JOURNAL OF MEDICAL CASES, 2022, 13 (08) : 374 - 379
  • [28] Disease Trajectory in anti-MDA5 Dermatomyositis Patients Presented with Different Stage of Interstitial Lung Disease
    Lan, Ting-Yuan
    Lee, Tai-Ju
    Chang, Ting-Wei
    Cheng, Chiao-Feng
    Shen, Chieh-Yu
    Lu, Cheng-Hsun
    Lin, Kuan-Yen
    Hsieh, Song-Chou
    Li, Ko-Jen
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2327 - 2328
  • [29] HRCT in accessing of interstitial lung disease in dermatomyositis with positive expression of anti-MDA5 autoantibody
    Diao, L.
    Chen, M.
    Zhu, X.
    Xue, K.
    Cao, H.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S1 - S1
  • [30] Fatal interstitial lung disease and pneumocystis during dermatomyositis associated with anti-MDA5 antibodies
    Seiller, H.
    Schmutz, J. -L.
    Poreaux, C.
    Bursztejn, A. -C.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2020, 147 (12): : 862 - 867
12345